United Therapeutics Corp(UTHR)
271.65
Change: -5.43 (▼ -2.00%)
As of Tue 12/20/2022 01:02 PM% Of Value
Growth
Value Per Share
:
:
:
226.84
13.63
81.4100 (as of 19/12/2022)
Fundamentals Data
| Open | 278.39 | Dividend | 46 |
| Close Price | 271.65 | DivYield | 0 % |
| High | 281.4 | Growth | 202.2 M |
| Low | 267.45 | Growth% | 13.63 |
| P/e | 9.316 | Volume | 458,729.0 |
| P/b | 20.68 | Market Capital | 12.1 B |
| Highest High | Lowest Low | ||
| 50 Days Moving Average | 252.82 (as of 21/12/2022) | 50 Days Moving Average Percentage | 6.9334069574821 (as of 21/12/2022 |
| Industry: Major Pharmaceuticals |
Charts for balance Sheet:
Balance Sheet Table: last 5 years
Note: Numbers are estimated, Exact figures can be found in Annual Reports
| Type | Year1 / 2017 | Year2 / 2018 | Year3 / 2019 | Year4 / 2020 | Current Year / 2021 |
| Revenue | 1.7 B | 1.6 B | 1.4 B | 1.4 B | 1.6 B |
| Cap Spending | -78.0 M | -184.4 M | -83.7 M | -56.9 M | -120.8 M |
| Operating Expenses | 804.7 M | 623.7 M | 1.5 B | 781.6 M | 1.0 B |
| Operating Cash Flow | 814.9 M | 805.4 M | -187.6 M | 593.6 M | 555.9 M |
| Free Cash Flow | 396.2 M | 594.0 M | -290.3 M | 698.8 M | 477.4 M |
| Free Cash Flow Per Share | 9.005 | 13.655 | -6.628 | 15.81 | 10.633 |
| Total liabilities | 250.0 M | 250.0 M | 850.0 M | 800.0 M | 800.0 M |
| Total cash | 705.1 M | 669.2 M | 738.4 M | 738.7 M | 894.8 M |
| ROE% | 0.209 | 0.226 | -0.04 | 0.162 | 0.128 |
| Outstanding Shares | 43.2 M | 43.7 M | 43.8 M | 44.5 M | 45.1 M |
| P/E | 12.641 | 9.316 | -44.435 | 15.03 | 15.908 |
| P/S | 3.062 | 3.372 | 3.205 | 5.216 | 4.491 |
| Revenue USD | 1.7 B | 1.6 B | 1.4 B | 1.4 B | 1.6 B |
| NO REPORTS FOR THIS STOCK |
Latest Searches
| Stock | Close Price | %of value | Date |
|---|